Foam sclerotherapy may result in drug and/or gas-related complications of a generalized or localized nature. Significant complications include anaphylactic/anaphylactoid reactions (very rare), deep vein thrombosis (1–3%), stroke (0.01%), superficial venous thrombosis (4.4%), tissue necrosis (variable frequency), oedema (0.5%) and nerve damage (0.2%). Cosmetic complications include telangiectatic matting (15–24%) and pigmentation (10–30%). Patent foramen ovale and other cardiopulmonary right-to-left shunts seem to play a role in the systemic gas-related complications. In conclusion, foam sclerotherapy is characterized by an overall high degree of safety, though special attention should be given to the embolic and thrombotic complications. Good technique, adequate imaging, general precautions and compliance with post-treatment instructions may help avoid some of the adverse events and an appropriate early intervention may minimize possible sequelae. Higher volumes of sclerosant foam have been attributed to local and distant thrombotic complications and should be avoided.
WollmannJC. The history of sclerosing foams.Dermatol Surg2004; 30: 694–703; discussion 10.1111/j.1524-4725. 2004.30208.x
2.
ThibaultP. Sclerotherapy and ultrasound-guided sclerotherapy. In: BerganJJ, ed. The Vein Book.Burlington, MA, USA: Academic Press, 2006: 189–200
3.
FrulliniA, CavezziA. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.Dermatol Surg2002; 28: 11–5
4.
GuexJJ, AllaertFA, GilletJL, ChleirF. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions.Dermatol Surg2005; 31: 123–8; discussion 8
5.
ParsiK. Paradoxical embolism, stroke and sclerotherapyPhlebol/Venous Forum R Soc Med2011. 10.1258/phleb.2011.010098
6.
MyersKA, JolleyD, CloughA, KirwanJ. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance.Eur J Vasc Endovasc Surg2007; 33: 116–21
7.
GilletJL, GuedesJM, GuexJJ. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients.Phlebol/Venous Forum R Soc Med2009; 24: 131–8
MyersKA, JolleyD. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins.Eur J Vasc Endovasc Surg2008; 36: 602–5
10.
GuexJJ. Complications of sclerotherapy: an update.Dermatol Surg2010; 36 (Suppl 2):1056–63
11.
JiaX, MowattG, BurrJM, CassarK, CookJ, FraserC. Systematic review of foam sclerotherapy for varicose veins.Br J Surg2007; 94: 925–36
12.
GilletJL, DonnetA, LauseckerM, GuedesJM, GuexJJ, LehmannP. Pathophysiology of visual disturbances occurring after foam sclerotherapy.Phlebol/Venous Forum R Soc Med2010; 25: 261–6
13.
ParsiK, PilotelleA, ConnorDE, LowJ, MaDDF, JosephJE. Low concentration detergent sclerosants induce platelet activation and microparticle release but inhibit aggregation in vitro. The XIII Annual Scientific Meeting and Workshops of The Australian College of Phlebology. Melbourne, Australia, 2011, 57
14.
FrulliniA, FeliceF, BurchielliS, Di StefanoR. High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy.Phlebol/Venous Forum R Soc Med2011; 26: 203–8
15.
MorrisonN, NeuhardtDL, RogersCR. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation.J Vasc Surg2008; 47: 830–6
16.
MaRW, PilotelleA, ParaskevasP, ParsiK. Three cases of stroke following peripheral venous interventions.Phlebol/Venous Forum R Soc Med2011; 26: 280–4
17.
ParsiK. Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications.Phlebol/Venous Forum R Soc Med2011; 26: 140–7
18.
MorrisonN. In: BerganJ, ChengV, eds. Studies on Safety of Foam Sclerotherapy. In Foam Sclerotherapy: A Textbook.London: Royal Society of Medicine Press, 2008
19.
ParsiK, ExnerT, ConnorDE, HerbertA, MaDD, JosephJE. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro.Eur J Vasc Endovasc Surg2008; 36: 216–23
20.
WrightD, RushJ, ButlerB. Polidocanol does not remain on the surface of bubbles free in the venous blood.Int Angiol2009; 4 (Suppl 1):39
21.
Schuller-PetrovicS, PavlovicMD, NeuholdN, BrunnerF, WolkartG. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.J Eur Acad Dermatol Venereol: JEADV2011; 25: 983–6
22.
GrommesJ, FranzenEL, BinneboselM. Inadvertent arterial injection using catheter-assisted sclerotherapy resulting in amputation.Dermatol Surg2011; 37: 536–8
23.
ParsiK, PartschH, RabeE, RameletAA. Reticulate eruptions. Part 1: Vascular networks and physiologyAustralas J Dermatol.2011; 52: 159–66
24.
ParsiK, PartschH, RabeE, RameletAA. Reticulate eruptions: Part 2. Historical perspectives, morphology, terminology and classification.Australas J Dermatol.2011; 52: 237–44
25.
BihariI, MagyarE. Reasons for ulceration after injection treatment of telangiectasia.Dermatol Surg2001; 27: 133–6
26.
CavezziA, FrulliniA, RicciS, TessariL. Treatment of varicose veins by foam sclerotherapy.Phlebology/Venous Forum R Soc Med2002; 17: 13–8
27.
GoldmanMP, SadickNS, WeissRA. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment.Dermatol Surg1995; 21: 19–29; quiz 31-2
28.
PalmMD, GuihaIC, GoldmanMP. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects.Dermatol Surg2010; 36 (Suppl 2):1026–33
29.
KernP, RameletAA, WutschertR, BounameauxH, HayozD. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.Dermatol Surg2004; 30: 367–72; discussion 72
30.
RaoJ, WildemoreJK, GoldmanMP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.Dermatol Surg2005; 31: 631–5; discussion 5
